beta

TLSA

Tiziana Life Sciences Plc

Chart

Stats

Earnings

News

Splits

Dividends

Earnings

Actual EPS
Consensus EPS
Estimated EPS
Number of Estimates
EPS Surprise

Stats

Summary

Tiziana Life Sciences Plc is a biotechnology company, which engages in the research and development of biotechnological and pharmaceutical products. Its lead product candidate in immunology is Foralumab (TZLS-401), which is a fully human anti-CD3 monoclonal antibody. The company was founded by Gabriele Marco Antonio Cerrone on November 4, 2013 and is headquartered in London, the United Kingdom.

Market Cap: 54.6 Million

Primary Exchange: NASDAQ

Website: http://www.tizianalifesciences.com

Shares Outstanding: 30.7 Million

Float:

Dividend: (%)

Beta: -0.885408663631124

Sector: Health Technology

Industry: Biotechnology

Ethical Flags

Longest drawdown: 1200 trading days

From: 2018-11-21 To: 2020-03-27

Lowest Point:

Ex-Date Payment Date Record Date Declared Date Amount Flag Dividend Type Qualified Indicated
Ex-Date Declared Date Record Date Payment Date Ratio To Factor For Factor
Data provided by IEX Cloud